Sukumar Nagendran, the President and Head of R&D of $TSHA, sold 110,125 shares of the company on 11-28-2025 for an estimated $523,093. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.9% of their shares of this class of stock. Following this trade, they now own 1,006,439 shares of this class of $TSHA stock.
$TSHA Insider Trading Activity
$TSHA insiders have traded $TSHA stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $TSHA stock by insiders over the last 6 months:
- SUKUMAR NAGENDRAN (President and Head of R&D) has made 0 purchases and 4 sales selling 627,226 shares for an estimated $2,504,509.
- KAMRAN ALAM (CHIEF FINANCIAL OFFICER) sold 54,491 shares for an estimated $155,299
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TSHA Hedge Fund Activity
We have seen 90 institutional investors add shares of $TSHA stock to their portfolio, and 75 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JEFFERIES FINANCIAL GROUP INC. removed 8,157,091 shares (-79.1%) from their portfolio in Q3 2025, for an estimated $26,673,687
- RTW INVESTMENTS, LP added 6,233,718 shares (+33.2%) to their portfolio in Q2 2025, for an estimated $14,399,888
- BARCLAYS PLC added 4,697,611 shares (+1042.8%) to their portfolio in Q3 2025, for an estimated $15,361,187
- OCTAGON CAPITAL ADVISORS LP removed 3,525,000 shares (-28.0%) from their portfolio in Q3 2025, for an estimated $11,526,750
- SUVRETTA CAPITAL MANAGEMENT, LLC removed 3,217,449 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,521,058
- BLACKROCK, INC. added 3,061,086 shares (+23.0%) to their portfolio in Q3 2025, for an estimated $10,009,751
- MPM BIOIMPACT LLC removed 2,953,562 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,658,147
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TSHA Analyst Ratings
Wall Street analysts have issued reports on $TSHA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/05/2025
- Chardan Capital issued a "Buy" rating on 11/05/2025
- Raymond James issued a "Strong Buy" rating on 10/21/2025
- Needham issued a "Buy" rating on 10/17/2025
- Baird issued a "Outperform" rating on 10/02/2025
- B of A Securities issued a "Buy" rating on 07/11/2025
To track analyst ratings and price targets for $TSHA, check out Quiver Quantitative's $TSHA forecast page.
$TSHA Price Targets
Multiple analysts have issued price targets for $TSHA recently. We have seen 8 analysts offer price targets for $TSHA in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Silvan Tuerkcan from Citizens set a target price of $8.0 on 11/05/2025
- Geulah Livshits from Chardan Capital set a target price of $12.0 on 11/05/2025
- Christopher Raymond from Raymond James set a target price of $13.0 on 10/21/2025
- Gil Blum from Needham set a target price of $10.0 on 10/17/2025
- Jack Allen from Baird set a target price of $12.0 on 10/02/2025
- Whitney Ijem from Canaccord Genuity set a target price of $14.0 on 08/13/2025
- Yanan Zhu from Wells Fargo set a target price of $8.0 on 08/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
